Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 21 May, 2014

JPMorgan Sec.Plc

Form 8.5 (EPT/RI)-AstraZeneca Plc-Amendment

RNS Number : 7539H
JPMorgan Securities Plc
21 May 2014
 



AMENDMENT

INCREASED TOTAL EQUITY PURCHASES FROM 6,294,813 TO 7,179,813.

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

AstraZeneca Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Pfizer Inc.

(d) Date dealing undertaken:

19 May 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

Pfizer Inc.

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Purchases

 

Sales

7,179,813

 

 5,605,924

44.0225 GBP

 

44.0000 GBP

41.0000 GBP

 

 40.9000 GBP

 

 (b)       Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBP)

Ordinary Shares

 

 

Equity Swap

 

 

Long

 

 

 

 

 

 

 

 

 

 

Short

 

 

143

 14,000

 10,000

 210,000

 5,000

 25

 270

 801

 4,407

 11,000

 

38,212

 12,500

 12,500

 5,000

 10,000

 10,000

 25,000

 25,000

 55,000

 350,000

 13,000

 500,000

 908

 4,020

 5,503

 205,000

 25,000

 110,000

 25,000

 25,000

 300,000

41.6150

 41.6808

 42.0650

 42.3805

 42.4673

 42.6052

 42.6144

 42.6150

 42.6153

 43.0934

 

 41.4972

 41.7707

 41.7709

 41.8528

 42.0000

 42.0032

 42.2191

 42.2353

 42.2473

 42.2576

 42.3209

 42.3367

 42.4305

 42.7963

 43.3816

 43.5397

 43.6975

 43.7931

 43.8668

 43.8819

 43.9175

 

 

(c)        Options transactions in respect of existing securities

 

(i)         Writing, selling, purchasing or varying

 

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

(GBP)

Type

e.g. American, European etc.

Expiry date

 

Option money paid/ received per unit

(GBP)

Ordinary Share

Call Option

Selling

11,800

46.00

American

20 Jun 14

0.5500

           

(ii)        Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

(GBP)





           

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)





 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

21 May 2014

Contact name:

Tung T Le

Telephone number:

020 7742 7272

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected].  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEREAXSFAENLEFF

a d v e r t i s e m e n t